Twin Lakes Capital Management, LLC
Source: SEC Form 13F · as of Mar 2026Twin Lakes Capital Management, LLC holds 8 biotech & pharma companies tracked by BioSniper, totaling $10.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$10.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 58,102 | $8.1M |
| INCYIncyte Corp. | 20,000 | $1.9M |
| ATHEAlterity Therapeutics Limited | 139,258 | $485K |
| JAZZJazz Pharmaceuticals plc | 1,554 | $294K |
| REGNREGENERON PHARMACEUTICALS, INC. | 158 | $122K |
| MRNAModerna, Inc. | 1,231 | $63K |
| BCABBioAtla, Inc. | 7,200 | $1K |
| OGNOrganon & Co. | 41 | $246 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.